Dysregulation of mTOR signaling is implicated in numerous diseases. In cancer, hyperactivation of mTOR promotes uncontrolled cell growth and survival. In metabolic disorders like diabetes, altered mTOR signaling affects insulin sensitivity and glucose metabolism. In neurodegenerative diseases, mTOR dysregulation impacts neuronal survival and function. Thus, mTOR is a critical target for therapeutic interventions in various pathological conditions.
